FDA Approves Blockbuster Weight Loss Drug
(The Hill) The Food and Drug Administration (FDA) approved Eli Lilly’s blockbuster diabetes drug for weight loss management on Wednesday, giving patients another tool and opening the door to potentially using much wider. Formal FDA approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely …